Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Safety of bosutinib versus imatinib in the phase 3 BELA trial in newly diagnosed chronic phase chronic myeloid leukemia.

Authors
Type
Published Article
Journal
American Journal of Hematology
1096-8652
Publisher
Wiley Blackwell (John Wiley & Sons)
Publication Date
Volume
89
Issue
10
Pages
947–953
Identifiers
DOI: 10.1002/ajh.23788
PMID: 24944159
Source
Medline

Abstract

Statistics

Seen <100 times